RxDoctor Payments Data

David Wang, MD

Interventional Pain Medicine · New York, NYNPI 1154374817

Payments from drug & device makers

$1,230in general payments, 2019–2025

Across 15 payments — averaging $82.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Si-bone, Inc.$352
  • Vertex$188
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$139
  • AstraZeneca$125
  • Biodelivery Sciences International, Inc.$125
  • Johnson & Johnson$119
  • plus $182 from 4 others

What the payments were for

  • Food & beverage$1,230100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,230 in reported general payments places this provider in the 30th percentile of 132 interventional pain medicine providers in New York.

See all interventional pain medicine providers in New York

Medicare billing

Part B allowed, 2024
$93,022
Medicare patients
120
Services billed
1,264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl66$41,538
BelbucaBuprenorphine Hcl42$23,379
NucyntaTapentadol Hcl15$9,962
Buprenorphine23$7,158
ButransBuprenorphine26$6,288
Lidocaine38$4,604
Oxycodone Hcl203$3,891
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen155$3,743
Hydromorphone Hcl116$2,033
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen64$1,628
Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol12$1,356
Naloxone Hcl19$1,189
Morphine Sulfate31$900
Pregabalin53$893
Gabapentin43$759

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →